Stock Research for SGMO

SGMO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SGMO Stock Chart & Research Data

The SGMO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SGMO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SGMO Due diligence Resources & Stock Charts

The SGMO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SGMO Detailed Price Forecast - CNN Money CNN View SGMO Detailed Summary - Google Finance
Yahoo View SGMO Detailed Summary - Yahoo! Finance Zacks View SGMO Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SGMO Trends & Analysis - Trade-Ideas Barrons View SGMO Major Holders - Barrons
NASDAQ View SGMO Call Transcripts - NASDAQ Seeking View SGMO Breaking News & Analysis - Seeking Alpha
Spotlight View SGMO Annual Report - CompanySpotlight.com OTC Report View SGMO OTC Short Report - OTCShortReport.com
TradeKing View SGMO Fundamentals - TradeKing Charts View SGMO SEC Filings - Bar Chart
WSJ View Historical Prices for SGMO - The WSJ Morningstar View Performance/Total Return for SGMO - Morningstar
MarketWatch View the Analyst Estimates for SGMO - MarketWatch CNBC View the Earnings History for SGMO - CNBC
StockMarketWatch View the SGMO Earnings - StockMarketWatch MacroAxis View SGMO Buy or Sell Recommendations - MacroAxis
Bullish View the SGMO Bullish Patterns - American Bulls Short Pains View SGMO Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SGMO Stock Mentions - StockTwits PennyStocks View SGMO Stock Mentions - PennyStockTweets
Twitter View SGMO Stock Mentions - Twitter Invest Hub View SGMO Investment Forum News - Investor Hub
Yahoo View SGMO Stock Mentions - Yahoo! Message Board Seeking Alpha View SGMO Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SGMO - SECform4.com Insider Cow View Insider Transactions for SGMO - Insider Cow
CNBC View SGMO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SGMO - OTC Markets
Yahoo View Insider Transactions for SGMO - Yahoo! Finance NASDAQ View Institutional Holdings for SGMO - NASDAQ


Stock Charts

FinViz View SGMO Stock Insight & Charts - FinViz.com StockCharts View SGMO Investment Charts - StockCharts.com
BarChart View SGMO Stock Overview & Charts - BarChart Trading View View SGMO User Generated Charts - Trading View




Latest Financial News for SGMO


3 Biotech Stocks With Major Catalysts Incoming
Posted on Monday August 13, 2018

Clinical trial results and an FDA approval decision will move these three stocks in the weeks ahead.


Sangamo Therapeutics Announces Presentation At The 2018 Wedbush PacGrow Healthcare Conference
Posted on Friday August 10, 2018

RICHMOND, Calif. , Aug. 10, 2018 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today that management will present a corporate overview at the 2018 Wedbush PacGrow Healthcare Conference ...


Sangamo Therapeutics Rose despite Q2 Sales Miss, Higher Losses
Posted on Thursday August 09, 2018

Sangamo Therapeutics reported second-quarter sales of $21.42 million, which just missed analysts’ estimate of $21.44 million in sales. This study evaluates SB-525 gene therapy for the treatment of hemophilia A. However, SGMO’s net loss declined on a sequential basis, and the company reported solid YoY (year-over-year) sales growth. Sangamo Therapeutics’ (SGMO) sales have risen ~160.0% on a YoY basis.


Why Sangamo Therapeutics, Inc. Stock Is Popping Today
Posted on Thursday August 09, 2018

The clinical-stage biotech reported encouraging news for its gene therapy targeting treatment of hemophilia A.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.